Vascular endothelial growth factor increases pulmonary vascular permeability in cystic fibrosis patients undergoing lung transplantation

European Journal of Cardio-thoracic Surgery

Volumn 32, Issue 1, 2007, Pages 35-41

  Krenn, Katharina ^a,b   Klepetko, Walter ^b   Taghavi, Shahrokh ^b   Paulus, Patrick ^a   Aharinejad, Seyedhossein ^a,b  

^a Medical University of Vienna   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cystic fibrosis; HIF; Lung transplantation; Vascular permeability; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GRAFT DYSFUNCTION; HUMAN; LUNG BLOOD VESSEL; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34249913445     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.04.006     Document Type: Article

References (22)

1. Kosorok M.R., Wei W.H., and Farrell P.M. The incidence of cystic fibrosis. Stat Med 15 (1996) 449-462
2. Crawford S., Stellmach V., McColley S., Jacobitz J., Backer C., and Bouck N. Elevated inducer of angiogenesis and increased microvascular density suggest a role for neovascularisation in cystic fibrosis. Pediatr Pulmonol Suppl 14 (1997) 296-297
3. McColley S.A., Stellmach V., Boas S.R., Jain M., and Crawford S.E. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 161 (2000) 1877-1880
4. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
5. Semenza G.L. HIF-1 and human disease: one highly involved factor. Genes Dev 14 (2000) 1983-1991
6. Hellwig-Burgel T., Stiehl D.P., Wagner A.E., Metzen E., and Jelkmann W. Review: hypoxia-inducible factor-1 (HIF-1): a novel transcription factor in immune reactions. J Interferon Cytokine Res 25 (2005) 297-310
7. Christie J.D., Carby M., Bag R., Corris P., Hertz M., Weill D., and ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
8. Taghavi S., Abraham D., Riml P., Paulus P., Schafer R., Klepetko W., and Aharinejad S. Co-expression of endothelin-1 and vascular endothelial growth factor mediates increased vascular permeability in lung grafts before reperfusion. J Heart Lung Transplant 21 (2002) 600-603
9. Abraham D., Taghavi S., Riml P., Paulus P., Hofmann M., Baumann C., Kocher A., Klepetko W., and Aharinejad S. VEGF-A and -C but not -B mediate increased vascular permeability in preserved lung grafts. Transplantation 73 (2002) 1703-1706
10. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156
11. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2 (2002) 38-47
12. Kasahara Y., Tuder R.M., Cool C.D., Lynch D.A., Flores S.C., and Voelkel N.F. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163 (2001) 737-744
13. Ratjen F., Hartog C.M., Paul K., Wermelt J., and Braun J. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax 57 (2002) 930-934
14. Dahlberg P.S., Prekker M.E., Herrington C.S., Hertz M.I., and Park S.J. Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation. J Heart Lung Transplant 23 (2004) 979-984
15. Kaner R.J., Ladetto J.V., Singh R., Fukuda N., Matthay M.A., and Crystal R.G. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol 22 (2000) 657-664
16. Le Cras T.D., Spitzmiller R.E., Albertine K.H., Greenberg J.M., Whitsett J.A., and Akeson A.L. VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 287 (2004) L134-L142
17. Godzich M., Hodnett M., Frank J.A., Su G., Pespeni M., Angel A., Howard M.B., Matthay M.A., and Pittet J.F. Activation of the stress protein response prevents the development of pulmonary edema by inhibiting VEGF cell signaling in a model of lung ischemia-reperfusion injury in rats. FASEB J. 20 9 (2006) 1519-1521
18. Gerber H.P., Condorelli F., Park J., and Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272 (1997) 23659-23667
19. Sawano A., Iwai S., Sakurai Y., Ito M., Shitara K., Nakahata T., and Shibuya M. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97 (2001) 785-791
20. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271 (1996) 736-741
21. Webb N.J., Myers C.R., Watson C.J., Bottomley M.J., and Brenchley P.E. Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10 (1998) 254-257
22. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257